[go: up one dir, main page]

MX2010011922A - Extracto de cistus que contiene ingredientes vegetales secundarios enriquecidos. - Google Patents

Extracto de cistus que contiene ingredientes vegetales secundarios enriquecidos.

Info

Publication number
MX2010011922A
MX2010011922A MX2010011922A MX2010011922A MX2010011922A MX 2010011922 A MX2010011922 A MX 2010011922A MX 2010011922 A MX2010011922 A MX 2010011922A MX 2010011922 A MX2010011922 A MX 2010011922A MX 2010011922 A MX2010011922 A MX 2010011922A
Authority
MX
Mexico
Prior art keywords
enriquecid
extract containing
vegetable ingredients
separate
cistus
Prior art date
Application number
MX2010011922A
Other languages
English (en)
Inventor
Feistel Björn
Walbroel Bernd
Original Assignee
Finzelberg Gmbh & Co Kg Star
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Finzelberg Gmbh & Co Kg Star filed Critical Finzelberg Gmbh & Co Kg Star
Publication of MX2010011922A publication Critical patent/MX2010011922A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Procedimiento para preparar un extracto que comprende como mínimo un 40% (m/m) de polifenoles de Cistus creticus L. con las siguientes etapas: - extraer partes de la planta de Cistus creticus L. con un extrayente que se selecciona del grupo que consiste de agua, alcoholes y mezclas de los mismos; - separar residuos de extracción; - separar por lo menos parcialmente el extrayente; - redisolver en un solvente acuoso y separar los componentes insolubles; - enriquecer selectivamente mediante por lo menos una de las siguientes etapas: a) una extracción en dos fases; b) una filtración en membrana.
MX2010011922A 2008-05-06 2009-05-06 Extracto de cistus que contiene ingredientes vegetales secundarios enriquecidos. MX2010011922A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08155699 2008-05-06
PCT/EP2009/055487 WO2009135880A1 (de) 2008-05-06 2009-05-06 Zistrosenextrakt mit angereicherten sekundären pflanzeninhaltsstoffen

Publications (1)

Publication Number Publication Date
MX2010011922A true MX2010011922A (es) 2011-03-02

Family

ID=40282426

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010011922A MX2010011922A (es) 2008-05-06 2009-05-06 Extracto de cistus que contiene ingredientes vegetales secundarios enriquecidos.

Country Status (4)

Country Link
US (1) US9173912B2 (es)
EP (1) EP2288361B1 (es)
MX (1) MX2010011922A (es)
WO (1) WO2009135880A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2575844B1 (de) * 2010-05-28 2016-11-23 Finzelberg GmbH & Co. KG Verfahren zur herstellung eines angereicherten extraktes aus blättern von weinrebengewächsen
DE102010055170A1 (de) * 2010-12-20 2012-06-21 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Verfahren zur Herstellung alkoholfreier Zusammensetzungen auf pflanzlicher Basis sowie auf diese Weise hergestellte Zusammensetzungen und deren Verwendung
EP2844263A1 (en) * 2012-05-04 2015-03-11 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Plant extract for the treatment of an hiv infection as well as products relating thereto
CN103948857A (zh) * 2014-05-13 2014-07-30 黄业武 一种慢性鼻窦炎鼻内镜术后的药物组合物
CN104162131A (zh) * 2014-08-13 2014-11-26 刘建煌 一种用于治疗鼻炎的药茶
DE102016002873A1 (de) 2016-03-09 2016-05-25 Heinz Kiefer Zellnachweisverfahren und Screeningverfahren von Stoffbibliotheken zur Identifizierung von Einzelstoffen, die im Falle einer bioterroristischen Bedrohung gegen Mischungen synthetischer Viren wirksam sind
CN108542987A (zh) * 2018-07-06 2018-09-18 邵显武 一种治疗鼻炎的中药组合物及其制备方法
TR2022000292A2 (tr) 2022-01-11 2022-02-21 Tuerkiye Bilimsel Veteknolojik Arastirma Kurumu SARS-CoV-2 Virüsüne Karşı Koruyucu Pastil/Çiğneme Tableti Üretimi
WO2024046653A1 (en) 2022-08-29 2024-03-07 Mycotech Pharma As Antiviral fungal extracts

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2416979C3 (de) 1974-04-08 1978-10-12 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt Verfahren zur Gewinnung des in den Wurzeln und Rhizomen von Helleborus-Arten enthaltenen Hauptsapogenins
GB9104286D0 (en) 1991-02-28 1991-04-17 Phytopharm Ltd Pharmaceutical compositions for the treatment of skin disorders
JPH06336421A (ja) 1993-05-28 1994-12-06 Kose Corp 皮膚外用剤
CN1102993A (zh) 1993-12-21 1995-05-31 吴文才 多酶体系加工中草药的制剂方法
ATE240088T1 (de) 1996-12-13 2003-05-15 Vesifact Ag Kosmetische präparate in form einer nanodispersion
US6024960A (en) 1998-04-17 2000-02-15 Otto Torbjorn Hansen And Marianne Hansen Rose-hip formulations as anti-inflammatory natural medicine for alleviating/reducing symptoms associated with inflammation and arthritis
US6576275B1 (en) * 1999-02-02 2003-06-10 Archer-Daniels-Midland Company Process for extracting polyphenolic antioxidants from purine-containing plants
HK1043361A1 (en) 1999-04-23 2002-09-13 Kyowa Hakko Kogyo Co., Ltd. Methods for purifying proanthocyanidin oligomers
JP2001072583A (ja) 1999-09-07 2001-03-21 Sunstar Inc 高脂血症の予防又は治療用組成物
JP4726022B2 (ja) 2000-03-28 2011-07-20 キッコーマン株式会社 抗アレルギー、抗炎症剤並びにこれを含有する医薬組成物、医薬部外品、化粧品、食品及び動物用飼料
US6485752B1 (en) 2000-10-23 2002-11-26 Otto Torbjorn Hansen Composition and method for alleviating joint pain and stiffness
PL213644B1 (pl) 2001-11-21 2013-04-30 H:S Rigshospitalet Zastosowanie glikozydów mono- i diacyloglicerolu do wytwarzania leku do leczenia, lagodzenia lub profilaktyki stanów zapalnych
JP2004113141A (ja) 2002-09-26 2004-04-15 Daawinzu:Kk Ｍｓｍ含有の健康食品
WO2004080993A1 (ja) * 2003-03-11 2004-09-23 Toyo Shinyaku Co., Ltd. プロアントシアニジン高含有物の製造方法
RU2240131C1 (ru) 2003-04-04 2004-11-20 Аладьев Сергей Иванович Средство "артровит" для профилактики и лечения артритов и артрозов
CN1928098A (zh) 2005-09-06 2007-03-14 童志清 一种精制番茄红素的方法
EP2286823B1 (en) * 2005-09-13 2015-06-17 Georgios Pandalis Extracts from plants of the genus Cistus for use in the prevention and/or treatment of influenza
US8017162B2 (en) 2005-10-26 2011-09-13 Oryza Oil & Fat Chemical Co., Ltd. Anti-inflammatory agent
FR2897238A1 (fr) 2006-02-15 2007-08-17 Novasep Soc Par Actions Simpli Procede de purification de la thaumatine
DE202006004872U1 (de) * 2006-03-10 2006-07-20 Icb Investment Consulting Und Beteiligungen Gmbh Mittel zur oralen Einnahme
ES2314772T3 (es) * 2006-03-24 2009-03-16 Georgios Pandalis Composicion para la prevencion y tratamiento de afecciones catarrales.
JP2007261987A (ja) 2006-03-28 2007-10-11 Sanki Shoji Kk チロシナーゼ阻害剤、その製法およびその応用
AU2006345937B2 (en) 2006-07-03 2011-08-11 Hyben Vital Licens Aps A method of preparing a glycoside of a mono- or diacylglycerol product from a plant material
JP5170577B2 (ja) 2006-07-14 2013-03-27 ディーエスエム アイピー アセッツ ビー．ブイ． 炎症障害の治療のためにバラの実および他の活性剤を含んでなる組成物
US8512769B2 (en) 2006-09-27 2013-08-20 Finzelberg Gmbh & Co. Kg Valerian extract preparation
RU2533273C2 (ru) 2007-12-21 2014-11-20 Финцельберг Гмбх Унд Ко. Кг Композиции с экстрактами плодов шиповника и способ получения экстрактов плодов шиповника
RU2355240C1 (ru) 2008-01-09 2009-05-20 Федеральное государственное образовательное учреждение высшего профессионального образования "Калининградский государственный технический университет" Способ получения пищевого препарата хондропротекторного действия
EP2130443A1 (en) 2008-06-06 2009-12-09 Finzelberg GmbH & Co. KG Water-soluble extracts of Artemisia dracunculus (tarragon) for improvement of glucose metabolism

Also Published As

Publication number Publication date
EP2288361A1 (de) 2011-03-02
WO2009135880A1 (de) 2009-11-12
US20110059190A1 (en) 2011-03-10
EP2288361B1 (de) 2013-08-21
US9173912B2 (en) 2015-11-03

Similar Documents

Publication Publication Date Title
MX2010011922A (es) Extracto de cistus que contiene ingredientes vegetales secundarios enriquecidos.
ES2406189R1 (es) Procedimiento para la extracción de lípidos a partir de biomasa de algas
MX2009013580A (es) Extracto que contiene equol, metodo para la produccion del mismo, metodo para la extraccion de equol, y alimento que contiene equol.
ECSP12011729A (es) Método de multiplicación vegetativas de plantas herbáceas
AR075518A1 (es) Procedimiento para la extraccion de compuestos fenolicos a partir de agua de vegetacion de la aceituna. polvo titulado en polifenoles de aceituna y de uva. composicion. uso
AR078647A1 (es) Metodo de purificacion de rebaudiosido d a partir del extracto de estevia y productos que lo contienen como endulzante.
EA021894B1 (ru) Способ обработки табачного материала
CL2009001479A1 (es) Metodo para aislar un alcaloide del veratrum desglicosilado que comprende proporcionar un material de planta veratrum, poner en contacto con una solucion acuosa y extraer el material de la planta veratrum con un solvente para proporcionar un extracto que comprende dicho alcaloide.
CY1116677T1 (el) Συνθεση που περιεχει πισεατανολη και μεθοδος παραγωγης αυτης
WO2018056936A3 (en) Enhanced herbal extraction and transdermal delivery
WO2009008697A4 (en) Extract from palm leaves and a method for producing the same
AR063035A1 (es) Metodo de enriquecimiento de glucorafanina en preparaciones con semilla de rabano.
AR090852A1 (es) Metodo y sistema para extraer yemas de un tallo de una planta graminacea
PE20140371A1 (es) Uso de por lo menos un coproducto de la industria de refinacion de aceite vegetal para obtener un producto total purificado de aceite vegetal insaponificable
CO2018001919A2 (es) Sistema y método para extraer aceites esenciales
BR112017017747A2 (pt) processo de preparação de um extrato de matriz vegetal com um composto anfifílico não iônico como adjuvante de extração em meio aquoso
AR084874A1 (es) Un extracto de helichrysum gymnocepahlum (dc) humbert enriquecido
CR20120039A (es) Un método para aumentar el nivel de aminoácidos libres en tejidos de almacenamiento de plantas perennes
AR075144A1 (es) Procedimiento para obtener una fraccion enriquecida en esteres de acidos grasos funcionalizados, a partir de semillas de plantas oleaginosas
CO2017010352A2 (es) Método para la elaboración de un extracto hidrosoluble de una biomasa vegetal
MX371133B (es) Composicion que comprende raphanus, theobroma y passiflora para el tratamiento del abuso de opiaceos y alcohol.
CL2013002172A1 (es) Procedimiento de preparacion de un extracto de fruto de momordica charantia (melón amargo o balsamina).
AR071579A1 (es) Efecto de la concentracion del carbohidrato sobre la eficencia de extraccion de la sucralosa
ES2628747T3 (es) Procedimiento para la producción de un extracto fungicida de Glycyrrhiza glabra estable en almacenamiento para el control de hongos fitopatogénicos y otras enfermedades en plantas
BR112018007475A2 (pt) ?solvente de extração e/ou solubilização, método para extrair compostos biológicos naturais, usos do solvente de extração e/ou solubilização e do extrato, e, extrato biológico natural?

Legal Events

Date Code Title Description
FG Grant or registration